Pediatric eosinophilic granulomatosis with polyangiitis participants treated with Mepolizumab in Europe, Trial ID 218065

Pediatric eosinophilic granulomatosis with polyangiitis participants treated with Mepolizumab in Europe, Trial ID 218065 | GSK